Authors:
Cereser, C
Guichard, J
Drai, J
Bannier, E
Garcia, I
Boget, S
Parvaz, P
Revol, A
Citation: C. Cereser et al., Quantitation of reduced and total glutathione at the femtomole level by high-performance liquid chromatography with fluorescence detection: application to red blood cells and cultured fibroblasts, J CHROMAT B, 752(1), 2001, pp. 123-132
Authors:
Boget, S
Cereser, C
Parvaz, P
Leriche, A
Revol, A
Citation: S. Boget et al., Fibroblast growth factor receptor 1 (FGFR1) is over-expressed in benign prostatic hyperplasia whereas FGFR2-IIIc and FGFR3 are not, EUR J ENDOC, 145(3), 2001, pp. 303-310
Citation: C. Cereser et al., Thiram-induced cytotoxicity is accompanied by a rapid and drastic oxidation of reduced glutathione with consecutive lipid peroxidation and cell death, TOXICOLOGY, 163(2-3), 2001, pp. 153-162
Authors:
Cachera, C
Baulac, M
Fagnani, F
Jallon, P
Leveau, J
Loiseau, P
Motte, J
Thomas, P
Vallee, L
Allaire, C
Autret, A
Baldy-Moulinier, M
Clanet, M
Dordain, G
Gastaut, JL
Giroud, M
Josien, E
Marescaux, C
Masnou, P
Mauguiere, F
Parain, D
Perret, J
Revol, M
Rumbach, L
Tapie, P
Weber, M
Adam, C
Attal, N
Attane, F
Aubrun, P
Ayrivie, N
Badinand-Hubert, N
Bapst-Reiter, J
Barthez-Carpentier, MA
Bartolomei, F
Bataillard, M
Bednarek, N
Belair, C
Benazet, M
Berges, S
Bergouignan, FX
Bernard, C
Bernard-Bourzeix, L
Bertran, F
Bertrand, P
Beuriat, P
Billard, C
Bille-Turc, F
Billy, C
Biraben, A
Blanc, A
Boidein, F
Bouayed, N
Boudon, S
Bouillat, J
Boulloche, J
Bredin, A
Brocard, O
Brosset, P
Brunet-Bourgin, F
Cenraud, B
Chaigne, D
Chaix, Y
Chaunu, MP
Chavot, D
Clavelou, P
Cohadon, S
Collombier, N
Contis, PE
Convers, P
Couchot, J
Cournelle, MA
Courtois, S
Croguennec, JM
Cuisset, JM
Cuvellier, JC
d'Anglejan, J
Damon, G
Danielli, A
Daubney, P
de Bellescize, J
de Lumley, L
de Recondo, A
de Swarte, M
Deffond, D
Delangre, T
Delisse, B
Derambure, P
Derambure, S
Desbordes, P
Desfrancois, F
Destee-Warot, M
Dien, J
Doremus, B
Dourneau-Lethiecq, MC
Dubois, F
Duche, B
Ducrocq, X
Duhurt, J
Duprey, J
Durand, G
Dusser, A
Escaillas, JP
Fanjaud, G
Felten, D
Fischer, C
Fontan, D
Formosa, F
Foulon, E
Furby, A
Gallet, S
Galmiche, J
Garde-Arthaud, P
Garrel, S
Gaultier, C
Gauthier, C
Gauthier-Morel, D
Genton, P
Geraud, G
Girard, JP
Girard-Madoux, M
Gonnaud, P
Goulon-Goeau, C
Gros, S
Grosclaude, M
Gross, M
Gueguen, B
Guinot, H
Haenggeli, CA
Hamon, JB
Henlin, JL
Hevin, B
Hinault, P
Homeyer, P
Hommet, C
Huart, E
Huc, P
Huttin, B
Inglesiakis, L
Isnard, J
Isnard, H
Jogeix, M
Juhel, C
Kahane, P
Kalafat, M
Keo-Kosal, P
Kreib, AM
Kubler, C
Larrieu, E
Larrieu, JL
Latinville, D
Le Gallou-Wittenberg, A
Lebas, F
Lebrun-Grandie, P
Leche, J
Legout, A
Legrand, S
Legroux, M
Lemaitre, JF
Lestavel, P
Levasseur, M
Lienhard, C
Livet, MO
Louiset, P
Lubeau, M
Lucas, B
Lucas-Daviaud, J
Maillard, S
Maillet-Vioud, M
Mancini, J
Mann, M
Marchal, C
Martini, L
Maupetit, J
Maynard, R
Menage, P
Menard, D
Metreau, R
Milor, M
Minot-Myhie, MC
Moene, Y
Montagne, B
Montelescaut, ME
Moreaud, O
Noelle, B
Olmi, X
Orbegozo, J
Ouvrard-Hernandez, AM
Parsa, A
Pautrizel, B
Pedespan, JM
Pernes, P
Perrouty, B
Petit, J
Peudenier, S
Picard, AM
Pierrot-Deseilligny, C
Planque, E
Portha, C
Preux, PM
Prud'homme, M
Raybaut-Guilhem, D
Rebaud, P
Regi, A
Regi, JL
Reis, J
Rejou, F
Remy, C
Renard, JF
Revenu, M
Revol, A
Rey, M
Richelme, C
Ricou, P
Rigal, JP
Rogez, R
Rousselle, C
Rummens, C
Ryvlin, P
Sabouraud, P
Saikali, I
Saudeau, D
Savet, JF
Schaeffer, JL
Schaff, JL
SCHoenfelder, F
Schuermans, P
Senant, J
Setiey, A
Sevrin, C
Sivelle, G
Soisson, T
Soubielle, P
Soulages, X
Soulayrol, S
Tabaraud, F
Taillandier, P
Tannier, C
Tarel, V
Taussig, D
Thedrez, F
Tournier, CL
Turc, JD
Vanhulle, C
Vaunaize, J
Verier, A
Vernay, D
Visy, JM
Vongsouthi, C
Vrigneaud, J
Waubant, E
Weichlein, A
Weill, O
Zai, L
Ziegler, F
Zix, C
de Zelicourt, M
Citation: C. Cachera et al., Epilepsies and time to diagnosis, REV NEUROL, 156(5), 2000, pp. 481-490
Authors:
Marcais, C
Bernard, S
Merlin, M
Ulhmann, M
Mestre, B
Rochet-Mingret, L
Revol, A
Berthezene, F
Moulin, P
Citation: C. Marcais et al., Severe hypertriglyceridaemia in Type II diabetes: involvement of apoC-III Sst-I polymorphism, LPL mutations and apo E3 deficiency, DIABETOLOG, 43(11), 2000, pp. 1346-1352